Condition: Mild Cognitive Impairment (MCI) · Sponsor: St. Joseph's Hospital and Medical Center, Phoenix
This pilot and feasibility study will enable the research team to determine the feasibility of implementing a time-restricted eating regimen among adults with mild cognitive impairment (MCI) and the impact of time-restricted eating on cognitive performance and biomarkers of metabolic health in this population. Study staff will execute the specific aims using a pre-post, non-randomized study design in which all participants receive the intervention. The intervention is a 16/8 time-restricted eating regimen characterized by fasting for 16 hours and eating within an 8-hour window on 5 days per week for 3 months. Assessments will be performed at baseline and after the 3-month time-restricted eating intervention with the following outcome measures. Outcome measures for feasibility include participant recruitment, retention and metrics of acceptability, safety, and adherence to the intervention. Outcome measures for cognitive performance and metabolic health include neuropsychological tests, blood biomarkers, and surveys of psychological well-being.
This description comes directly from the study's public registry record.
Yonas E Geda, MD, MSc · 833-233-3073 · yonas.geda@commonspirit.org
Geetika Chahal, MBBS · 602-406-7240 · geetika.chahal@commonspirit.org
Always discuss trial participation with your own doctor first.
| Arizona State University, College of Health Solutions | Phoenix, Arizona, United States | Recruiting |
| Barrow Neurological Institute, Division of Alzheimer's Disease | Phoenix, Arizona, United States | Enrolling By Invitation |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06429124